Can sterile and pyrogen-free on-line substitution fluid be routinely delivered? A multicentric study on the microbiological safety of on-line haemodiafiltration

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 1, 2000, Pages 74-78

  Vaslaki, L ^a   Karatson A ^b   Voros P ^c   Major, L ^d   Petho F ^e   Ladanyi E ^f   Weber, C ^g   Mitteregger, R ^h   Falkenhagen, D ^h  

^a Erzsébet Hospital   (Hungary)

^b Fresenius Medical Care in Hungary   (Hungary)

^c Szent Istvan Hospital   (Hungary)

^d Dialysis Centre Esztergom   (Hungary)

^e Dialysis Ctr Salgotarjan   (Hungary)

^f Fresenius Medical Care in Hungary   (Hungary)

^g FRESENIUS MEDICAL CARE   (Germany)

^h DANUBE UNIVERSITY KREMS   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DIALYSIS FLUID; ENDOTOXIN; PYROGEN; SODIUM CHLORIDE; WATER;

BACTERIUM; CONFERENCE PAPER; CYTOKINE PRODUCTION; DEVICE; DIALYSIS MEMBRANE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; IMMUNOCOMPETENT CELL; INFECTIOUS COMPLICATION; NONHUMAN; ONLINE SYSTEM; PRIORITY JOURNAL; SAFETY; ULTRAFILTRATION; WATER CONTAMINATION;

EID: 0342514769     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027968     Document Type: Conference Paper

References (22)

1. Arvanitidou M, Spaia S, Katsinas C, et al. Microbiological quality of water and dialysate in all haemodialysis centres of Greece. Nephrol Dial Transplant 1998; 13: 949-954
2. Pass T, Wright R, Sharp B, Harding GB. Culture of dialysis fluids on nutrient-rich media for short periods at elevated temperatures underestimate microbial contamination. Blood Purif 1996; 14: 136-145
3. Bambauer R, Schauer M, Jung WK, Daum V, Vienken J. Contamination of dialysis water and dialysate. A survey of 30 centers. ASAIO J 1994; 40: 1012-1016
4. Schindler R, Krautzig S, Lufft V, et al. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in vitro dialysis with whole blood. Nephrol Dial Transplant 1996; 11: 101-108
5. Tsuchida K, Takemoto Y, Yamagami S, et al. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and Limulus amebocyte lysate methods. Nephron 1997; 75: 438-443
6. Baz M, Durand C, Ragon A, et al. Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 1991; 14: 681-685
7. Girndt M, Köhler H, Schiedhelm-Weick E, Schlaak JF, Meyer zum Büschenfelde KH, Fleischer B. Production of interleukin-6, tumor necrosis factor α and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 1995; 47: 559-565
8. Kimmel PL, Phillips TM, Simmens SJ, et al. Immunologic function and survival in hemodialysis patients. Kidney Int 1998; 54: 236-244
9. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658
10. Erley CM, von Herrath D, Amir-Moazami B, Schaefer K. Beneficial effect of a bacteria and pyrogcn reduced dialysate on the occurence of fever during hemodialysis. A prospective study. J Nephrol 1989; 4: 257-260
11. Pegues DA, Oettinger CW, Bland LA, et al. A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J Am Soc Nephrol 1992; 3: 1002-1007
12. Canaud B, Flavier JL, Argilés A, et al. Haemodiafiltration with on-line production of substitution fluid: long-term safety and quantitative assessment of efficacy. Contrib Nephrol 1994; 108: 12-22
13. Weber C, Stummvoll HK, Passon S, Falkenhagen D. Monocyte activation and humoral immune response to endotoxins in patients receiving on-line hemodialfiltration therapy. Int J Artif Organs 1998; 21: 335-340
14. Pizzarelli F, Cerrai T, Dattolo P, Tetta C, Maggiore Q. Convective treatments with on-line production of replacement fluid: a clinical experience lasting 6 years. Nephrol Dial Transplant 1998; 13: 363-369
15. The European pharmacopoeia, bacterial endotoxins, 3rd edn. Supplement. The European Department for the Quality of Medicines within the Council of Europe 1998; 29-37
16. Krautzig S, Linnenweber S, Schindler R, Shaldon S, Koch KM, Lonnemann G. New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients. Nephrol Dial Transplant 1996; 11 (Suppl. 2): 87-91
17. Lonnemann G, Schindler R. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate. Clin Nephrol 1994; 42: S37-S43
18. Dinarello CA. Pathogenesis of fever during hemodialysis. Contrib Nephrol 1983; 36: 90-99
19. Frei U, Koch KM. Fever and shock during hemofiltration. Contrib Nephrol 1983; 36: 107-114
20. Quellhorst E, Hildebrand U, Soif A. Long-term morbidity: Hemofiltration vs. hemodialysis. Contrib Nephrol 1995; 113: 110-119
21. Pereira BJG, Snodgrass BR, Hogan PJ, King AJ. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kidney Int 1995; 47: 603-610
22. Ronco C, Brendolan A, Feriani M, et al. A new scintigraphic method to characterize ultrafiltration in hollow fiber dialyzers. Kidney Int 1992; 41: 1383-1393